Patents Assigned to REVASCARDIO LTD.
-
Publication number: 20260090825Abstract: Devices, systems, and methods for intraluminal puncturing system are disclosed. A first catheter has a flexible positioning arm extending from a distal end thereof and being configured for delivery within an anatomical vessel. The flexible positioning arm is configured to transition between a collapsed orientation and an expanded orientation. A second catheter is disposed within the first catheter and has an opened distal end affixed to the positioning arm such that when the flexible positioning arm is in the expanded orientation, the opened distal end opposes a wall of the anatomical vessel. An elongated shaft is extendable through the second catheter. A tissue puncturer is located on a distal end of the elongated shaft. The tissue puncturer is configured for axial advancement in the second catheter and operably connected to the opened distal end of the second catheter.Type: ApplicationFiled: December 9, 2025Publication date: April 2, 2026Applicant: REVASCARDIO LTD.Inventors: David Shlomo CHAYEN, Dotan Asher CHAYEN, Shahaf MARMOR, Chaim Zeev ABER, Oded MEIRI
-
Publication number: 20260060685Abstract: Devices, systems, and methods for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium are disclosed. Devices and methods include a method for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium, the method comprising: implanting a variable occluder in a coronary sinus region proximate a left atrium, wherein the variable occluder is configured to gradually increase a level of blood flow restriction over a period of days to enable a venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of blood flow restriction; and following venous system compensation, shunting oxygenated blood flow into the coronary sinus to cause retrograde flow of oxygenated blood in at least a portion of the venous system of the myocardium to thereby enable revascularization of the myocardium.Type: ApplicationFiled: November 11, 2025Publication date: March 5, 2026Applicant: REVASCARDIO LTD.Inventors: Shahaf MARMOR, Oded MEIRI, Assaf ALON, Chaim Zeev ABER, David Shlomo CHAYEN
-
Patent number: 12533499Abstract: Devices, systems, and methods for revascularization of the myocardium are disclosed, such as an intravascular medical device for shunting and selectively regulating anatomical fluid flow. A tubular shunt is configured for deployment in a passageway between a first organ and a second adjacent organ and to bridge a first cavity in the first organ and a second cavity in the second organ. A stabilizer is configured to stabilize the tubular shunt in the passageway. A flow deflector extends from the tubular shunt and has a surface for deflecting flow in the second cavity.Type: GrantFiled: April 8, 2025Date of Patent: January 27, 2026Assignee: REVASCARDIO LTD.Inventors: David Shlomo Chayen, Oded Meiri, Dotan Asher Chayen, Shahaf Marmor, Chaim Zeev Aber, Eric Cohen
-
Patent number: 12514611Abstract: Devices, systems, and methods for intraluminal puncturing system are disclosed. A first catheter has a flexible positioning arm extending from a distal end thereof and being configured for delivery within an anatomical vessel. The flexible positioning arm is configured to transition between a collapsed orientation and an expanded orientation. A second catheter is disposed within the first catheter and has an opened distal end affixed to the positioning arm such that when the flexible positioning arm is in the expanded orientation, the opened distal end opposes a wall of the anatomical vessel. An elongated shaft is extendable through the second catheter. A tissue puncturer is located on a distal end of the elongated shaft. The tissue puncturer is configured for axial advancement in the second catheter and operably connected to the opened distal end of the second catheter.Type: GrantFiled: May 20, 2025Date of Patent: January 6, 2026Assignee: REVASCARDIO LTD.Inventors: David Shlomo Chayen, Dotan Asher Chayen, Shahaf Marmor, Chaim Zeev Aber, Oded Meiri
-
Patent number: 12490989Abstract: Devices, systems, and methods for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium are disclosed. Devices and methods include a method for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium, the method comprising: implanting a variable occluder in a coronary sinus region proximate a left atrium, wherein the variable occluder is configured to gradually increase a level of blood flow restriction over a period of days to enable a venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of blood flow restriction; and following venous system compensation, shunting oxygenated blood flow into the coronary sinus to cause retrograde flow of oxygenated blood in at least a portion of the venous system of the myocardium to thereby enable revascularization of the myocardium.Type: GrantFiled: April 2, 2025Date of Patent: December 9, 2025Assignee: REVASCARDIO LTD.Inventors: Shahaf Marmor, Oded Meiri, Assaf Alon, Chaim Zeev Aber, David Shlomo Chayen
-
Publication number: 20250302479Abstract: Devices, systems, and methods for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium are disclosed. Devices and methods include a method for causing retrograde oxygenated blood flow in at least a portion of the venous system of the myocardium, the method comprising: implanting a variable occluder in a coronary sinus region proximate a left atrium, wherein the variable occluder is configured to gradually increase a level of blood flow restriction over a period of days to enable a venous system of the myocardium to compensate for increased pressure caused by the gradual increase in the level of blood flow restriction; and following venous system compensation, shunting oxygenated blood flow into the coronary sinus to cause retrograde flow of oxygenated blood in at least a portion of the venous system of the myocardium to thereby enable revascularization of the myocardium.Type: ApplicationFiled: April 2, 2025Publication date: October 2, 2025Applicant: REVASCARDIO LTD.Inventors: Shahaf MARMOR, Oded MEIRI, Assaf ALON, Chaim Zeev ABER, David Shlomo CHAYEN
-
Publication number: 20250281201Abstract: Devices, systems, and methods for intraluminal puncturing system are disclosed. A first catheter has a flexible positioning arm extending from a distal end thereof and being configured for delivery within an anatomical vessel. The flexible positioning arm is configured to transition between a collapsed orientation and an expanded orientation. A second catheter is disposed within the first catheter and has an opened distal end affixed to the positioning arm such that when the flexible positioning arm is in the expanded orientation, the opened distal end opposes a wall of the anatomical vessel. An elongated shaft is extendable through the second catheter. A tissue puncturer is located on a distal end of the elongated shaft. The tissue puncturer is configured for axial advancement in the second catheter and operably connected to the opened distal end of the second catheter.Type: ApplicationFiled: May 20, 2025Publication date: September 11, 2025Applicant: REVASCARDIO LTD.Inventors: David Shlomo CHAYEN, Dotan Asher CHAYEN, Shahaf MARMOR, Chaim Zeev ABER, Oded MEIRI
-
Publication number: 20250235676Abstract: Devices, systems, and methods for revascularization of the myocardium are disclosed, such as an intravascular medical device for shunting and selectively regulating anatomical fluid flow. A tubular shunt is configured for deployment in a passageway between a first organ and a second adjacent organ and to bridge a first cavity in the first organ and a second cavity in the second organ. A stabilizer is configured to stabilize the tubular shunt in the passageway. A flow deflector extends from the tubular shunt and has a surface for deflecting flow in the second cavity.Type: ApplicationFiled: April 8, 2025Publication date: July 24, 2025Applicant: REVASCARDIO LTD.Inventors: David Shlomo CHAYEN, Oded MEIRI, Dotan Asher CHAYEN, Shahaf MARMOR, Chaim Zeev ABER, Eric COHEN
-
Publication number: 20250099727Abstract: An intravascular retrograde blood flow device is disclosed. The device comprises a catheter; an expandable shunt compressed within the catheter and configured to bridge an opening between a first cavity of a first organ and a second cavity of a second organ; an expandable flow deflector compressed within the catheter and configured to deflect flow in the second cavity; and a flexible hinge interconnecting the expandable shunt and the expandable flow deflector. The flexible hinge is bendable to enable transverse axial positioning of the expandable shunt and the expandable flow deflector while maintaining an interconnection between the expandable shunt and the expandable flow deflector.Type: ApplicationFiled: August 30, 2024Publication date: March 27, 2025Applicant: REVASCARDIO LTD.Inventors: David Shlomo CHAYEN, Oded MEIRI, Dotan Asher CHAYEN, Shahaf MARMOR, Chaim Zeev ABER, Eric COHEN